-
What is purified water equipment?
Time of Update: 2022-06-01
2. Adopt imported reverse osmosis membrane, high desalination rate, long service life and low operating cost .
9. The reverse osmosis unit has a high degree of automation, and the workload of operation and maintenance and equipment maintenance is very small .
-
European Medicines Agency: mRNA new crown vaccine is not associated with autoimmune hepatitis
Time of Update: 2022-05-31
In this regard, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) announced on April 8 that there is currently no evidence to support a causal relationship between the mRNA new crown vaccine and autoimmune hepatitis (AIH), and no update is currently required.
-
The 2021 financial report competition of the four major pharmaceutical distribution giants: Sinopharm’s revenue exceeds 500 billion, and the net profit of Jiuzhoutong drops by 20%
Time of Update: 2022-05-31
In the net profit attributable to the parent in 2021, Sinopharm Holding, Shanghai Pharmaceuticals, China Resources Pharma, and Jointown achieved 7.
Sinopharm Holding's pharmaceutical distribution business will have sales of nearly 390 billion yuan in 2021, a year-on-year increase of 12.
-
Sun Lei, Director of the Device Review Center: Promote the reform of the medical device review and approval system in depth
Time of Update: 2022-05-30
The Medical Device Technology Review Center of the State Food and Drug Administration (hereinafter referred to as the Device Review Center) carefully plans, establishes rules and regulations, and makes solid progress, optimizes the review process, standardizes review work, implements review science, and continuously improves review quality and efficiency.
-
In 2022, the tide of layoffs in foreign Biotech is coming, and 46 companies including Merck, Biogen, Novartis, Sanofi, and Gilead are listed!
Time of Update: 2022-05-30
6 billion immuno-oncology drug development collaboration with Bristol-Myers Squibb, the company announced a strategic reorganization that will cut 70% of its workforce, including its chief medical officer and chief commercial officer, two key executives.
-
Star drug DS-8201 is about to land in China!
Time of Update: 2022-05-30
The basic information of ADC drugs currently approved by the US FDA and EU EMA for breast cancer treatment is shown in Table 1 .
-
Another Priority Review Voucher was born, who is the last "oriole"
Time of Update: 2022-05-30
More than half of the new drugs approved by the FDA this time are related to children's indications, which shows the FDA's attitude towards children's medicines, and also reflects that the research and development of children's medicines in the United States has entered a period of accelerated growth, and domestic pharmaceutical companies should pay attention .
-
No.58 20 projects of medical and health financing have been invested, and Shanghai's financing amount ranks first!
Time of Update: 2022-05-30
(hereinafter referred to as "Emisen") completed the C round of financing of more than 100 million yuan, The funds invested this time will be used for market expansion, new product research and development, clinical trials, registration applications, etc.
-
What are the advantages of a fully automatic video melting point apparatus compared to traditional testing methods?
Time of Update: 2022-05-30
Fully automatic measurement Video, atlas, data are automatically recorded, stored in association, and cumbersome operation steps are removed, making up for the defects that traditional detection methods cannot test in dark samples .
-
Bayer poachs another GSK executive to lead its strategic oncology business unit
Time of Update: 2022-05-30
Both Tara Frenkl and Christine Roth were previously at GSK, with Frenkl previously serving as senior vice president and head of oncology drug development at GSK, while Roth was a senior GSK global oncologist before joining Bayer on March 1.
At Bayer, Roth and Frenkl will focus on developing the prostate cancer drug Nubeqa .
-
2021 Global Drug Market Pattern in Top 10 Hot Fields: PD-1/PD-L1, BTK, HER2, CDK4/6...
Time of Update: 2022-05-30
3 BTK In 2021, no new BTK inhibitors will be launched globally, and there are still 5 products in the market, with a scale of more than 11 billion US dollars .
-
Breaking through the inward siege, domestic innovative drugs enter the 2 trillion market!
Time of Update: 2022-05-30
Since China joined ICH in 2017, there have been more than 10 domestic innovative drugs submitted for marketing in the United States, and 10 license-out projects worth over 1 billion yuan.
-
The Southern Institute lowered its forecast for the growth of the pharmaceutical economy in 2022 to 10.5%, and the industrial development has entered a period of adjustment (live video attached)
Time of Update: 2022-05-30
Lin Jianning, Secretary of the Party Committee of the Southern Medical Economics Research Institute of the State Food and Drug Administration 0 1 0 1 1 New variables trigger growth adjustments New variables trigger growth adjustments Under the new normal of epidemic prevention and control, the growth rate of the pharmaceutical economy has dropped significantly: the operating income of the pharmaceutical manufacturing industry in the first quarter of this year increased by 5.
-
Novartis 2022Q1｜Nuoxinto medical insurance takes effect, driving a strong growth of 16% in the Chinese market
Time of Update: 2022-05-30
5% Innovative Medicines Sector Sandoz Source: Novartis Financial ReportThe main drivers of Novartis' innovative business in the quarter were: heart failure drug Nuxinto (sacubitril/valsartan sodium) grew by 42%, and quarterly sales exceeded $1 billion for the first time; autoimmune disease drug Cantilever (secukinumab) up 12%; spinal muscular atrophy drug Zolgensma (Onasemonogene abeparvovec) up 18%; allergic asthma drug Zole (omalizumab) up 17%; breast cancer drug ribociclib ( ribociclib) grew 28%; the recently launched multiple sclerosis drug ofatumumab contributed $195 million .
-
In a few minutes, you can understand the precautions for the use of the capsule counting machine
Time of Update: 2022-05-30
If it is too high, please use a lathe to process the washer under the disc (do not make it too low) .
If it is too low or too high, the capsule will be damaged .
-
Watson Bio's 2022 Q1 financial report: revenue increased by 51%
Time of Update: 2022-05-30
The company achieved an operating income of 656 million yuan, an increase of 51.
During the reporting period, the Yuxi Watson 13-valent pneumonia conjugate vaccine, a subsidiary of Watson, received batches of 2,085,700 doses, an increase of 26.
-
Potential Analysis of the Decrease and the Selection Rate of the Centralized Procurement of Chinese Patent Medicines
Time of Update: 2022-05-30
2. Group A, non-exclusive drop distribution A purchase order has a total of 278 products to be selected, with an average decline of 47.
-
You can lose up to 24kg!
Time of Update: 2022-05-30
"Tirzepatide is the first investigational drug to reduce average body weight by more than 20% in a Phase 3 clinical trial, and these results reinforce our confidence in its potential to help people with obesity, " said Dr.
-
648 days, the first in the country!
Time of Update: 2022-05-30
Zhang Yan waited 26 months for this news . On April 6, 2022, Wang Jingjing, deputy chief physician of the Department of Nephrology, Children's Hospital Affiliated to Zhejiang University School of M
-
GSK 2022Q1 results: revenue increased by 32%!
Time of Update: 2022-05-30
307 billion pounds in the first quarter, but due to the supply agreement signed with the government, GSK expects Xevudy's full-year revenue to be close to 2021, about 1.
